Clinical Research Directory
Browse clinical research sites, groups, and studies.
Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation
Sponsor: Medinutra LLC
Summary
Two dietary supplements are each being compared to a placebo for the ability to help maintain triglycerides in the normal range. The subjects will be adult men and women with moderately high TG values. Serum triglycerides will be measured before and after 6 weeks of taking 1 capsule per day of either Longvida Curcumin, astaxanthin, or a placebo. A few side blood analysis will also be done. These measures are relevant to low level inflammation.
Official title: Curcumin and Astaxanthin for Lowering Triglyceride Readings and Inflammation
Key Details
Gender
All
Age Range
21 Years - 59 Years
Study Type
INTERVENTIONAL
Enrollment
64
Start Date
2025-07-18
Completion Date
2025-12
Last Updated
2025-08-01
Healthy Volunteers
Yes
Conditions
Interventions
Curcumin (Longvida™)
1 capsule per day at a usual curcumin dose for this particular product (80 mg curcumin)
Half Dose Curcumin (Longvida™)
1 capsule per day at half the usual curcumin dose for this particular product (40 mg curcumin as the half dose)
Astaxanthin
1 capsule per day at a usual astaxanthin dose (12 mg)
Placebo Control
Subject will get 1 capsule per day of a small amount of cellulose
Locations (1)
Medinutra LLC
Dublin, Ohio, United States